Laboratory Corporation of America Holdings (LH)

240,57 +2,77 (+1,16%) Alla chiusura: 4:00PM EST

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
http://www.labcorp.com

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 65.160

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Adam H. Schechter	Pres, CEO & Chairman	1,79M	N/D	1965
Mr. Glenn A. Eisenberg	CFO & Exec. VP	1,46M	N/D	1961
Mr. Lance V. Berberian	Exec. VP and Chief Information & Technology Officer	876,62k	N/D	1963
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH	Exec. VP, Pres of Diagnostics & Chief Medical Officer	3,36M	N/D	1974
Mr. Mark S. Schroeder	Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain	3,19M	N/D	1961
Dr. Michelle Abelson	Laboratory Director of Operations	N/D	N/D	N/D
Mr. Peter J. Wilkinson	Sr. VP & Chief Accounting Officer	N/D	N/D	1971
Dr. Marcia T. Eisenberg	Chief Scientific Officer & Sr. VP	N/D	N/D	N/D
Clarissa Willett	VP of Investor Relations	N/D	N/D	N/D
Ms. Sandra D. Van Der Vaart	Exec. VP, Chief Legal Officer, Chief Compliance Officer & Corp. Sec.	N/D	N/D	1960

Gli importi risalgono al giorno 31 dicembre 2019 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Governance aziendale

L'ISS Governance QualityScore di Laboratory Corporation of America Holdings al 3 dicembre 2020 è 2. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 6; diritti degli azionisti: 1; retribuzione: 5.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.